Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents.
about
Pathogenesis and pathophysiology of bacterial meningitis.Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response.New therapies and vaccines for bacterial meningitis.Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.Hearing impairment after bacterial meningitis: a review.Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain.Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptidesEvaluation of vancomycin for therapy of adult pneumococcal meningitis.Animal models as predictors of the safety and efficacy of antibiotics.Inflammatory properties of antibiotic-treated bacteria.Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.Animal models in the evaluation of antimicrobial agents.Corticosteroids in bacterial meningitis.
P2860
Q30450181-769496AB-9341-475D-A350-454A437A66B2Q34194556-A9D450C3-34B7-477E-9956-C50F2FE6AB06Q34768547-6205D08B-9BE3-48C0-85A9-744FAF76E7FDQ35119049-D3BA5E15-2328-4CD3-BC36-A42E7E41EACEQ35448193-EC31F9AB-2C63-4293-8C30-2236A09780CCQ35590092-8D862F8D-4BA9-4CB9-B261-8CA18633564EQ36067379-50E549E0-DE8F-43FF-BA91-CEFF774D6807Q36365745-5A1292B6-431D-43EB-951B-853421A31A20Q36757364-2B3C1A03-AA2C-4957-BD12-5978B38D6545Q37977580-D92FBBFC-27D1-45A8-9614-4C2E3E5B6C88Q38941353-E0762759-B3F2-4F25-BCF7-4AEC29955D48Q39826721-5BBE6C5A-E4BA-4B4D-8128-358D3479D295Q40087019-7A466FE2-6B95-461F-8928-5A47D4F247F7Q42681706-80A84C8B-DECF-437B-9B53-A5F96AB6F5AF
P2860
Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Cerebrospinal fluid protein pr ...... and anti-inflammatory agents.
@en
Cerebrospinal fluid protein pr ...... and anti-inflammatory agents.
@nl
type
label
Cerebrospinal fluid protein pr ...... and anti-inflammatory agents.
@en
Cerebrospinal fluid protein pr ...... and anti-inflammatory agents.
@nl
prefLabel
Cerebrospinal fluid protein pr ...... and anti-inflammatory agents.
@en
Cerebrospinal fluid protein pr ...... and anti-inflammatory agents.
@nl
P2093
P356
P1476
Cerebrospinal fluid protein pr ...... and anti-inflammatory agents.
@en
P2093
Hengstler B
Kadurugamuwa JL
P356
10.1093/INFDIS/159.1.26
P407
P577
1989-01-01T00:00:00Z